T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.84B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.1B |
| 4 |
Bank of America
BAC
|
+$860M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$618M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$25.3B |
| 2 |
Tesla
TSLA
|
+$2.19B |
| 3 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 4 |
JPMorgan Chase
JPM
|
+$1.29B |
| 5 |
Booking.com
BKNG
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.45% |
| 2 | Healthcare | 18.09% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Financials | 13.39% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
AngioDynamics
ANGO
$647M
| $10.9M | ﹤0.01% |
478,254
+4,439
| +0.9% | +$96.4K |
|
1302
Endava
DAVA
$167M
| $10.9M | ﹤0.01% |
397,469
+3,477
| +0.9% | +$87.6K |
|
|
DRNA
1303
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $10.9M | ﹤0.01% |
746,039
+413,424
| +124% | +$4.75M |
|
1304
Ranger Energy Services
RNGR
$405M
| $10.8M | ﹤0.01% |
1,353,004
+4,345
| +0.3% | +$31.8K |
|
1305
Helmerich & Payne
HP
$4.3B
| $10.7M | ﹤0.01% |
193,304
+26,300
| +16% | +$1.43M |
|
1306
Harley-Davidson
HOG
$2.9B
| $10.7M | ﹤0.01% |
299,280
+8,578
| +3% | +$312K |
|
1307
Affiliated Managers Group
AMG
$9.7B
| $10.6M | ﹤0.01% |
98,903
+1,180
| +1% | +$125K |
|
1308
Quanta Services
PWR
$101B
| $10.6M | ﹤0.01% |
280,580
-2,200
| -0.8% | -$76.8K |
|
1309
nLIGHT
LASR
$2.9B
| $10.5M | ﹤0.01% |
473,104
+272,762
| +136% | +$5.52M |
|
1310
Qiagen
QGEN
$8.93B
| $10.4M | ﹤0.01% |
241,649
+13,265
| +6% | +$534K |
|
|
ZAYO
1311
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $10.3M | ﹤0.01% |
363,987
+29,819
| +9% | +$791K |
|
1312
Erie Indemnity
ERIE
$13.4B
| $10.3M | ﹤0.01% |
57,786
+3,130
| +6% | +$503K |
|
|
SPTN
1313
DELISTED
SpartanNash
SPTN
| $10.3M | ﹤0.01% |
647,517
-614,396
| -49% | -$11.8M |
|
1314
RPC Inc
RES
$1.39B
| $10.3M | ﹤0.01% |
898,805
| – | – |
|
|
MDSO
1315
DELISTED
Medidata Solutions, Inc.
MDSO
| $10.1M | ﹤0.01% |
137,820
+1,921
| +1% | +$139K |
|
1316
Krystal Biotech
KRYS
$9.72B
| $10M | ﹤0.01% |
304,120
+600
| +0.2% | +$14.1K |
|
1317
Leggett & Platt
LEG
$1.32B
| $10M | ﹤0.01% |
236,966
+14,300
| +6% | +$601K |
|
1318
Wayfair
W
$13.9B
| $9.9M | ﹤0.01% |
66,726
-98,004
| -59% | -$12.8M |
|
|
USX
1319
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $9.86M | ﹤0.01% |
1,492,239
+50,816
| +4% | +$395K |
|
1320
Ichor Holdings
ICHR
$2.67B
| $9.81M | ﹤0.01% |
434,525
-12,067
| -3% | -$246K |
|
|
CSS
1321
DELISTED
CSS Industries, Inc.
CSS
| $9.81M | ﹤0.01% |
1,637,800
+1,670
| +0.1% | +$13.5K |
|
1322
Markel Group
MKL
$22.8B
| $9.77M | ﹤0.01% |
9,803
+581
| +6% | +$590K |
|
1323
Nu Skin
NUS
$236M
| $9.75M | ﹤0.01% |
203,755
-93,820
| -32% | -$5.69M |
|
|
AYX
1324
DELISTED
Alteryx Inc
AYX
| $9.74M | ﹤0.01% |
116,172
+58,329
| +101% | +$4.21M |
|
1325
Donaldson
DCI
$11.1B
| $9.73M | ﹤0.01% |
194,318
-13,742
| -7% | -$664K |
|
Similar funds
T. Rowe Price Associates's Q1 2019 Portfolio in Review
As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates withdrew a net $28.8B in Q1 2019, closing 86 positions and reducing 714 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $1.55B position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Fox Class B worth $420M.
- T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
- T. Rowe Price Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $25.3B.
- T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
- T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
- T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.